Literature DB >> 7453091

Treatment of diabetes insipidus complicated by diabetes mellitus with chlorpropamide and clofibrate.

M Manns, J Schneider, K H Meyer zum Büschenfelde.   

Abstract

A patient with severe idiopathic diabetes insipidus, complicated by diabetes mellitus, was first treated with a combination o clofibrate and chlorpropamide. Urine volume dropped from 18 litres/day (CH2O = 10.5 ml/min) to 3.1-5.1 litres/day (CH2O = -0.1 -+1.1 ml/min) under treatment. Ten months after the beginning of therapy treatment was maintained with chlorpropamide alone; no significant rise in urine volume was observed. After 18 months when therapy was stopped for 5 days urine volume rose to 11.7 litres/day maximum (CH2O = 6.6 ml/min). No obvious side effects occurred under treatment during a follow up for over 18 months. Serum levels for arginine vasopressin before and under treatment were below 1.0 pg/ml. Determination of free water clearance (CH2O) proved to be a highly sensitive and simple method for follow up controls. It is discussed whether the coincidental manifestation of diabetes insipidus and diabetes mellitus may be caused by a single molecular lesion. This hypothesis is supported by data which imply that in both disease chlorpropamide acts via a common molecular mechanism, the blocking of endogenous prostaglandin E2 biosynthesis. Finally a treatment with oral "non-hormonal" drugs like clofibrate and chlorpropamide should be taken into consideration in some cases of diabetes insipidus as is demonstrated by this case report.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7453091     DOI: 10.1007/bf01491106

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  14 in total

1.  Prolongation of duration of action of 1-deamino-8-D-arginine vasopressin (DDAVP) by ineffective doses of clofibrate in diabetes insipidus.

Authors:  J P Radó; J Marosi
Journal:  Horm Metab Res       Date:  1975-11       Impact factor: 2.936

2.  Coexistence of diabetes insipidus and diabetes mellitus in a seven year old girl.

Authors:  G H LOWREY
Journal:  Am J Dis Child       Date:  1950-07

3.  A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators.

Authors: 
Journal:  Br Heart J       Date:  1978-10

Review 4.  A hypothesis for the molecular mechanism of action of chlorpropamide in the treatment of diabetes mellitus and diabetes insipidus.

Authors:  R M Zusman; H R Keiser; J S Handler
Journal:  Fed Proc       Date:  1977-12

5.  Potentiation of vasopressin action by chlorpropamide in vivo.

Authors:  M Miller; A M Moses
Journal:  Endocrinology       Date:  1970-05       Impact factor: 4.736

6.  Coexistence of diabetes mellitus and insipidus and optic atrophy in two male siblings. Studies and review of literature.

Authors:  G W Bretz; A Baghdassarian; J D Graber; B J Zacherle; R A Norum; R M Blizzard
Journal:  Am J Med       Date:  1970-03       Impact factor: 4.965

7.  [Combined clofibrate-chlorpropamide therapy in diabetes insipidus complicated with diabetes mellitus].

Authors:  L Czakó; F A László; I Kahán-László
Journal:  Endokrinologie       Date:  1975-08

8.  Antidiuretic action of chlorpropamide in idiopathic diabetes insipidus.

Authors:  F Arduino; F P Ferraz; J Rodrigues
Journal:  J Clin Endocrinol Metab       Date:  1966-12       Impact factor: 5.958

9.  [Preliminary study of antidiuretic effect of clofibrate (or atromid S) in pitressosensitive diabetes insipidus].

Authors:  J L de Gennes; C Bertrand; B Bigorie; J Truffert
Journal:  Ann Endocrinol (Paris)       Date:  1970 Mar-Apr       Impact factor: 2.478

10.  Clofibrate-induced antidiuresis.

Authors:  A M Moses; J Howanitz; M van Gemert; M Miller
Journal:  J Clin Invest       Date:  1973-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.